The Daily Overview on MSNOpinion
350 US meds get pricier as drugmakers push ahead anyway
Drug companies are starting 2026 by lifting list prices on a huge slate of brand name medicines, even as the White House and ...
Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for ...
Industry analysis examines published SURMOUNT clinical trial data, evolving FDA compounding guidance, and telehealth access ...
Historically, rural areas have been hardest hit by access shortages due to unequal distribution of resources and services — a ...
According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is projected to expand significantly to US$105.83 billion by 2033, registering ...
MONDAY, Dec. 29, 2025 (HealthDay News) — CBD and other cannabis derivatives are a bust when it comes to pain relief, a new ...
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage Resolution Reshapes Weight Loss Medication LandscapeBluffdale, Dec.
Typical retail pricing: According to manufacturer announcements, Novo Nordisk has described a limited-time cash-pay savings offer structure for Wegovy injection (e.g., $199 for initial doses, then ...
Walking into Pitt Street Pharmacy is like stepping back into the 1930s and a world many would have loved to experience.
Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable ...
Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...
TORONTO, ONTARIO / ACCESS Newswire / December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) (“Quantum BioPharma“),understands that Quantum BioPharma shareholder Paul Durkacz has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results